These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 15920908)
41. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study. Bini EJ; Mehandru S Arch Intern Med; 2004 Nov; 164(21):2371-6. PubMed ID: 15557418 [TBL] [Abstract][Full Text] [Related]
42. Clinical trial: comparison of weekly once versus twice half-dose weekly administration of pegylated interferon alpha 2b in combination with ribavirin for the treatment of HCV-1 positive patients with chronic hepatitis C. Sebastiani G; Ferrari A; Boccato S; Pistis R; Alberti A Aliment Pharmacol Ther; 2007 Oct; 26(7):1077-82. PubMed ID: 17877515 [TBL] [Abstract][Full Text] [Related]
43. Disease and treatment outcome in chronic active hepatitis C with occult HBV infection. Berberova M; Mendizova A; Popchristova E; Krastev N; Genov J Hepatogastroenterology; 2003; 50(54):2009-12. PubMed ID: 14696454 [TBL] [Abstract][Full Text] [Related]
44. Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients. Itose I; Kanto T; Inoue M; Miyazaki M; Miyatake H; Sakakibara M; Yakushijin T; Oze T; Hiramatsu N; Takehara T; Kasahara A; Katayama K; Kato M; Hayashi N J Med Virol; 2007 May; 79(5):511-21. PubMed ID: 17385691 [TBL] [Abstract][Full Text] [Related]
45. Combination therapy with interferon-alpha 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection. Kallinowski B; Liehr H; Moeller B; Stremmel W; Wechsler JG; Wiese M; Goeser T Z Gastroenterol; 2001 Mar; 39(3):199-204, 206. PubMed ID: 11324136 [TBL] [Abstract][Full Text] [Related]
46. New therapies for chronic hepatitis C virus infection. Dev A; Patel K; McHutchison JG Curr Gastroenterol Rep; 2004 Feb; 6(1):77-86. PubMed ID: 14720458 [TBL] [Abstract][Full Text] [Related]
49. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Gitlin N Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):883-5. PubMed ID: 12172411 [TBL] [Abstract][Full Text] [Related]
50. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. Doi F; Kakizaki S; Takagi H; Murakami M; Sohara N; Otsuka T; Abe T; Mori M Liver Int; 2005 Apr; 25(2):242-6. PubMed ID: 15780045 [TBL] [Abstract][Full Text] [Related]
51. Acute west nile virus in two patients receiving interferon and ribavirin for chronic hepatitis C. Hrnicek MJ; Mailliard ME Am J Gastroenterol; 2004 May; 99(5):957. PubMed ID: 15128371 [No Abstract] [Full Text] [Related]
52. Uterine sarcoidosis potentially associated with interferon-alpha use for chronic hepatitis C infection. Tsiodras S; Drimala P; Stavreas N; Dachlythras M; Alamani AM; Naoum G Obstet Gynecol; 2005 May; 105(5 Pt 2):1198-201. PubMed ID: 15863580 [TBL] [Abstract][Full Text] [Related]
53. Pegylated interferon-induced eyelid and eyebrow trichomegaly during chronic hepatitis C. Howaizi M J Gastroenterol Hepatol; 2005 Dec; 20(12):1945-6. PubMed ID: 16336462 [TBL] [Abstract][Full Text] [Related]
54. Successful long-term application of highly purified natural interferon-alpha (multiferon) after preceding interferon approaches in a chronic hepatitis C patient with thrombocytopenia. Musch E; Malek M; von Eick H; Chrissafidou A Scand J Infect Dis; 2004; 36(5):395-9. PubMed ID: 15287392 [TBL] [Abstract][Full Text] [Related]
55. Bell's palsy: a rare complication of interferon therapy for hepatitis C. Hwang I; Calvit TB; Cash BD; Holtzmuller KC Dig Dis Sci; 2004 Apr; 49(4):619-20. PubMed ID: 15185866 [No Abstract] [Full Text] [Related]
56. Severe Raynaud's phenomenon with chronic hepatis C disease treated with interferon. Iorio R; Spagnuolo MI; Sepe A; Zoccali S; Alessio M; Vegnente A Pediatr Infect Dis J; 2003 Feb; 22(2):195-7. PubMed ID: 12613457 [TBL] [Abstract][Full Text] [Related]
57. Interferon therapy: the other face of the medal. Licata A; Craxì A Ann Ital Med Int; 2004; 19(1):5-7. PubMed ID: 15176703 [No Abstract] [Full Text] [Related]
58. Consensus interferon induced interstitial pneumonitis in a patient with HCV. Hillier AE; Mand J; Raza A; Markov M; Nadir A Am J Gastroenterol; 2006 Jan; 101(1):200-2. PubMed ID: 16405558 [No Abstract] [Full Text] [Related]
59. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Mistry N; Shapero J; Crawford RI Can J Gastroenterol; 2009 Oct; 23(10):677-83. PubMed ID: 19826642 [TBL] [Abstract][Full Text] [Related]